Atherton, CA, United States of America

Colin J McKinlay

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Alberton, CA (US) (2020)
  • Atherton, CA (US) (2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):

Title: Colin J McKinlay: Innovator in Drug Delivery Systems

Introduction

Colin J McKinlay is a notable inventor based in Atherton, California. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on cell-penetrating compounds.

Latest Patents

Colin J McKinlay holds two patents, with his latest focusing on cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery. These transporter compounds are designed to facilitate the delivery of therapeutic agents to target cells. The patents detail methods of making and using these compounds, which can be formulated with pharmaceutically acceptable excipients. The formulations may be provided in unit doses that are effective for achieving desired therapeutic effects. The methods described can be applied both in vitro and in vivo, showcasing the versatility and potential impact of his inventions.

Career Highlights

Colin J McKinlay is affiliated with Leland Stanford Junior University, where he continues to advance research in the field of drug delivery. His work has garnered attention for its innovative approach to enhancing the efficacy of pharmaceutical compositions.

Collaborations

Colin has collaborated with esteemed colleagues such as Paul A Wender and Robert M Waymouth, contributing to a rich environment of innovation and research.

Conclusion

Colin J McKinlay's contributions to drug delivery systems exemplify the intersection of science and innovation. His patents reflect a commitment to improving therapeutic outcomes through advanced delivery methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…